CompletedNCT03179696
Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaBehavioural studyAges 18–65
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT00314639
Modafinil as an Adjunctive on Cognitive Functioning in people with Schizophrenia
Official study title
The Impact of Modafinil as an Adjunctive to a Second Generation Antipsychotic on Cognitive Functioning in Schizophrenia and Schizophrenia Spectrum Psychosis.
This study has finished and is no longer accepting participants.
In QuébecSchizophreniaMedication studyAges 18+
CompletedNCT02576613
Modified Psychodynamic Psychotherapy for people with Schizophrenia
Official study title
Modified Psychodynamic Psychotherapy for Patients With Schizophrenia - a Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In BerlinSchizophreniaInterventional studyAges 18–65
CompletedNCT05746455
Motivation Skills Training for Schizophrenia
Official study title
Motivation Skills Training to Enhance Functional Outcomes for People With Schizophrenia (Open Trial)
This study has finished and is no longer accepting participants.
In New YorkSchizophreniaBehavioural studyAges 18–65
CompletedNCT02504476
Safety study of AMG 581 in schizophrenia
Official study title
A Phase I, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective Disorder on Antipsychotic Medication
This study has finished and is no longer accepting participants.
In GlendaleSchizophreniaMedication studyAges 18–45
CompletedNCT01384604
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
Official study title
Neurophysiological and Genetic Studies in Schizophrenia and Other Psychiatric Disorders
This study has finished and is no longer accepting participants.
In DallasSchizophrenia, BipolarityObservational studyAges 15–70
CompletedNCT06653829
NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
This study has finished and is no longer accepting participants.
In RochesterSchizophreniaDevice studyAges 18–65
CompletedNCT05582980
Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia
Official study title
Online High-definition Transcranial Direct Current Stimulation Over the Left Dorsolateral Prefrontal Cortex During a Working Memory Task for Treating Negative Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaDevice studyAges 20–65
CompletedNCT00088465
Study of Intramuscular Olanzapine Depot in people with Schizophrenia or Schizoaffective Disorder
Official study title
An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including OrangeSchizophreniaMedication studyAges 18–76
Active Not RecruitingNCT06251193
Optimizing CBSST With Executive Function Training for Schizophrenia
Official study title
Optimizing Cognitive Behavioral Social Skills Training With Executive Function Training for Older Adults With Schizophrenia
This study is no longer accepting new participants.
Multiple locations, including La JollaSchizophreniaBehavioural studyAges 60+
CompletedNCT02055287
Pharmacokinetic and Safety Study of LY03004 in Stable people with Schizophrenia or Schizoaffective Disorder
What is this study about?
This study evaluated the safety of LY03004 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including OrangeSchizophreniaMedication studyAges 18–65
CompletedNCT01788774
Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths
Official study title
Phase I, Open-Label, Randomized, Parallel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of One Intramuscular Injection of Risperidone ISM® at Different Dose Strengths in Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ZagrebSchizophreniaMedication studyAges 18–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.